PaxMedica, Inc. Common Stock
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intra…
Biotechnology
US, Tarrytown [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
PaxMedica, Inc. Common Stock can't present it's latest revenue by geo. area
Historical Revenue By Segment
Last 3Y, in mil. USDPaxMedica, Inc. Common Stock can't present revenue by segment